C. Mautalén - Concepedia

Author

C. Mautalén

Also Known As

C A Mautalen, C A Mautalén, C MAUTALEN, C Mautalen, C Mautalén, C. A. MAUTALEN, C. A. Mautalen, C. MAUTALEN, C. Mautalen, C. Mautalén

216

Publications

11.7K

Citations

H-Index

111

Concepts

All Affiliations

Universidad de Buenos Aires Hospital de Clínicas "José de San Martín"Hospital de Clínicas University of Liège Bone Health and Osteoporosis Foundation

About

C. Mautalén is an author at Universidad de Buenos Aires specializing in medicine, osteoporosis, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	67	3.8K
2	Health Sciences	18	26	1K
3	Public Health	7	7	1K
4	Anatomy	2	2	111
5	Applied Physiology	2	2	177

C. Mautalén

Publications

10.7K

Citations

H-Index

Page 1

	Year	Citations
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis Dennis M. Black, Pierre D. Delmas, Richard Eastell, New England Journal of Medicine	2007	2.9K
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture Kenneth W. Lyles, Cathleen Colón‐Emeric, Jay Magaziner, New England Journal of Medicine	2007	2K
Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis Harry K. Genant, Cyrus Cooper, Gyula Poór, Osteoporosis International Bone DiseaseBone HealthHealth PolicyMetabolic Bone DiseaseInternational Health	1999	782
Prevention and management of osteoporosis : report of a WHO scientific group E. Barrett-Connor, Debra Black, J.‐P. Bonjour, White Rose Research Online (University of Leeds, The University of Sheffield, University of York) Bone DiseaseBone HealthPreventive MedicineOsteopathyWho Scientific Group	2003	360
Sustained Vertebral Fracture Risk Reduction After Withdrawal of Teriparatide in Postmenopausal Women With Osteoporosis Robert Lindsay, Wim H. Scheele, Robert M. Neer, Archives of Internal Medicine	2004	325
The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study Socrates E. Papapoulos, Kurt Lippuner, Christian Roux, Osteoporosis International	2015	275
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos, The Lancet Diabetes & Endocrinology Bone DiseaseOsteopathyLoft Extension StudyMedicineGynecology	2019	164
Bone mineral affection in asymptomatic adult patients with celiac disease. Roberto M. Mazure, Horacio Vázquez, Deli Nazmín Tirado‐González, PubMed	1994	157
Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass Harry K. Genant, Klaus Engelke, Michael A. Bolognese, Journal of Bone and Mineral Research	2016	138
Long‐term effect of gluten restriction on bone mineral density of patients with coeliac disease Jie Bai, D. González, C. Mautalén, Alimentary Pharmacology & Therapeutics	1997	124

Page 1